Imidazo(4,5-f)quinolines useful as immunomodulating agents
申请人:Norwich Eaton Pharmaceuticals, Inc.
公开号:EP0187705A2
公开(公告)日:1986-07-16
The present invention involves compounds of the class of imidazo[4, 5-f]quinolines and methods for enhancing the immune response system of mammals which comprises systemically administering to mammals having a depressed immune function an effective but nontoxic amount of a composition comprising such a compound.